newsfilter
← Latest News
GlobeNewswire·

Cyclerion Therapeutics to Present at Annual Biomarkers for Alzheimer's Disease Summit

CAMBRIDGE, Mass., Aug. 23, 2021 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (NASDAQ:CYCN), a clinical-stage biopharmaceutical company on a mission to develop treatments that restore cognitive function, today announced participation in the Annual B